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by-nc-nd/4.0/).See Clinical Research on Page 468D espite decades of experiencewith both peritoneal dialysis
(PD) and hemodialysis (HD), ne-
phrologists around the world
continue to debate sthe optimal
dialysis modality. Wide
geographic variations exist, with
Hong Kong, the pioneer of PD
first, having the highest preva-
lence of PD patients at approxi-
mately 70%. In contrast, the
United States is currently at 10%
to 12%, and Japan stands at
approximately 5% PD prevalence.1
Lately, the U.S. president’s execu-
tive order has mandated increasing
the use of home dialysis modalities
over the next 5 years, including
the use of PD, necessitating
U.S.-based nephrologists to be
more cognizant of PD, its outcomes,
and its complications.
Recent research has shown that
dialysis staff with less training and
enthusiasm for PD are associated
with lower rates of PD initiation,Correspondence: Kamyar Kalantar-Zadeh,
Division of Nephrology and Hypertension,
University of California Irvine Medical
Center, 101 The City Drive, Suite 400, Or-
ange, California 92868-3217, USA. E-mail:
kkz@uci.edu
Kidney International Reports (2020) 5, 389–391reflecting possibly a negative bias
regarding its suitability for pa-
tients.2 Regardless, the incidence
rates of PD have risen over the past
several years, at least in the United
States, possibly reflecting patient
preferences for home-based modal-
ities or our increasing awareness
and comfort regarding this modal-
ity. In addition, the U.S. govern-
ment has increased reimbursement
rates for PD since 2011, which also
may have helped hasten the rise of
PD. Whether by government
mandate, patient preference,
physician competence, or changing
reimbursement models, the number
of PD patients is expected to
continue to rise over time. Keeping
in mind our own limitations and
biases, striving for a more complete
understanding of PD will un-
doubtedly improve outcomes,
decrease our own partiality against
this modality, and align our treat-
ments to patient preferences.
The fundamental question of
whether the PD modality inher-
ently has better outcomes than HD
when controlling for patient fac-
tors has not yet been answered by
randomized trials, despite several
attempts to do so and a recent389study suggesting that there are no
differences in mortality out-
comes.3,4 In both attempted ran-
domized controlled trials in the
United States and the Netherlands,
investigators failed to randomize
appropriately due to patient pref-
erences for modality type, high-
lighting that patient preferences
remain the driver for selecting the
dialysis modality. It is also known
that incident PD patients are
generally healthier and have
higher residual kidney function at
baseline compared with HD pa-
tients, possibly leading to
improved mortality and morbidity
outcomes in observational studies.
Attempts to overcome randomiza-
tion issues, including the use of
sophisticated statistical modeling
techniques as propensity score or
instrumental variable analyses
have been pursued with some
degree of success, but the inherent
issue of nonrandomization with
residual confounding still persists
as a methodological flaw of the
observational study design.4
Notwithstanding the limitations
of observational studies, the quest
to improve our understanding of
PD outcomes should continue,
especially in understanding the
complications of this modality and
the reasons for its technique fail-
ure. In the United States, PD
technique failure rates are
approximately 20%, 40%, and
55% at 1, 2, and 3 years, respec-
tively.5 Although PD failure oc-
curs for a variety of reasons,
because of peritonitis, inadequate
dialysis, catheter malfunction, or
psychosocial factors, traditionally
many patients had no choice but to
convert to thrice-weekly in-center
hemodialysis. This is in sharp
contrast to the fast-emerging
concept of incremental dialysis,
whereby incident dialysis patients
with adequate residual kidney
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Figure 1. Traditional and novel options to transition from peritoneal dialysis (PD) to hemo-
dialysis (HD).
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>3 ml/min) who meet certain
criteria are nowadays expected to
transition to twice-weekly HD for
the first several months.6 Over the
past several years, the concept of
incremental dialysis has gained
substantial acceptance in the
United States and abroad, given its
nature of patient-centeredness and
its alliance with the basic princi-
ples of precision medicine.7 The
University of California Irvine in-
cremental dialysis model that is
also practiced at the Veterans Af-
fairs Medical Center in Long
Beach, California, has emerged as
the prevailing model of twice-
weekly HD transition throughout
the nation and beyond.8 Based on
our unpublished data, no patients
have died out of more than 100
incident dialysis patients who
initiated twice-weekly HD since
2014 and maintained this infre-
quent HD regimen between 3
months to 3 years before they
transitioned to thrice-weekly HD.
This is in contrast to the high
mortality rate during the first year
after dialysis transition that has
been described relatively consis-
tently on outright initiation of
conventional thrice-weekly HD.6
Nevertheless, the use of incre-
mental dialysis is not quite clear.390More unclear is the utility of other
precision medicine–based ap-
proaches in dialysis therapy
realms, including combining HD
and PD. In a recent concept model,
Gedney (who is a dialysis patient)
and Kalantar-Zadeh9 proposed
translating the incremental model
to incident PD patients using
shorter dwell times, less daily so-
lution volume, or fewer than 7
dialysis treatment days per week.
A gradual transition to more
frequent or more intense dialysis
therapy over several months can
then be used to counter worsening
fluid retention and uremia.9 These
authors also suggest that if less
frequent PD is desired, PD may be
combined with sporadic HD treat-
ments, although there are few data
about the benefits and challenges
of such combination approaches.
To that end, if PD appears to be
inadequate on further reduction in
residual kidney function, sporadic
HD therapies in addition to back-
ground PD, such as once-weekly
HD, can be considered (Figure 1).
In the current edition of KI Re-
ports, Tanaka et al.10 have investi-
gated hospitalization outcomes in
patients converted to a combination
of PD and HD, a modality that is
rarely heard of in the United States
or Western Europe. Investigatorsmatched prevalent HD patients with
42 combined PD and HD patients,
most (37, or 88% of the combined
PD-HD cohort) of whom were con-
verted from PD due to inadequate
dialysis or volume overload. There
did not appear to be any significant
differences in hospitalization rates
between the combination PD-HD
cohort versus the HD cohort, but
investigators unsurprisingly noted
an increase in hospitalizations for
dialysis access-related issues in the
combined PD-HD cohort, including
vascular complications and PD-
related infections of 21.7 per 100
patient-years versus 7.2 per 100
patient-years, respectively.
Many readers may take these
interesting results to suggest that
the combined modality should not
be offered and that patients should
be switched directly to HD when
PD failure occurs given the
increased risk of dialysis access
complications. However, the fact
that total hospitalization rates did
not differ between the 2 groups
may suggest an alternative
approach whereby patients main-
tain the independence of PD while
slowly, instead of abruptly, tran-
sitioning to HD (Figure 1). Quality
of life, maintenance of indepen-
dence, and the ability to perform a
life-sustaining treatment on one’s
own schedule is an important
consideration. This is especially
true in the era of precision medi-
cine, incremental transitions in
dialysis, and more intense focus on
patient-reported outcomes. Our
experience with transitioning pa-
tients from chronic kidney disease
5 to dialysis via the University of
California Irvine twice-weekly in-
cremental dialysis model for pa-
tients who meet eligibility criteria6
has improved compliance, main-
tained residual kidney function,
and improved long-term out-
comes.11 The transition from full
PD to combined PD-HD can be
likened as a similar transitionKidney International Reports (2020) 5, 389–391
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disease and HD, one which can
potentially avoid the constant he-
modynamic changes seen in HD
and its associated poor outcomes.
There are inherent limitations to
this small, nonrandomized study
from Japan,10 including the lack of
individual dialysis PD prescription
details before transition and indi-
vidual patient characteristics that
make it difficult to ascertain if
adjusting the PD prescription may
have prevented them from
switching to the combination mo-
dality. The small study in a limited
geographical area with a homoge-
neous patient population will also
affect generalizability of these
findings to other non-Asian coun-
tries, especially because most dial-
ysis centers around the world are
not capable (logistically or other-
wise) of performing such combi-
nation dialysis treatments.
Furthermore, mortality outcomes
in this study and optimal dialysis
adequacy targets for combination
modality patients overall remains
unknown. Although larger studies
that investigate the feasibility and
outcomes of the combined PD-HD
dialysis modality over the long-
term are needed, this small but
important study points to an
avenue to assist patients with the
transition from PD to HD.
Ultimately, modality selection
must remain the patient’s decision,
but having an improved under-
standing of the modalities and its
complications, in addition to con-
siderations when transitioningKidney International Reports (2020) 5, 389–391patients to and from various mo-
dalities, will undoubtedly improve
the education of our patients,
remove our personal biases against
the PD modality, and enhance
outcomes both here in the United
States and abroad. There are many
advantages to using precision
medicine tools to institute incre-
mental dialysis and combined HD-
PD protocols. These include longer
preservation of residual kidney
function, avoidance of the abrupt
transition from PD to thrice-
weekly HD on PD technique fail-
ure, improved adherence to patient
preference, and allowance for a
greater patient-centeredness.
Although we are uncertain that a
combined HD-PD will ultimately
become a favorable treatment
choice globally, we remain highly
enthusiastic of innovative dialysis
and nondialysis options and
combinations.DISCLOSURE
All the authors declared no
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